Skip to main content
Premium Trial:

Request an Annual Quote

A Contract Researcher's Life

David Perrey at Chemical Space says that working a contract position at a non-profit research institute is much like his former, full-time research gig, though the salary and benefits are different. "I am paid hourly now ... so hours count," Perrey says. "And if I am not at work, I don't get paid." While overtime is an option, he says it's one that must be agreed upon in advance. As a temporary employee, Perrey also says his "benefits are another big difference," as they are arranged and administered by his contract employment agency rather than by the institute where he works. "They are not in business to offer long vacations and comprehensive insurance plans," he says of the agency, though he adds that his benefits are "enough to get by" on. Overall, Perrey says doing research as a temporary employee is very similar to doing it as a full-time one, "but it is in the perks and especially the benefits that a contractor feels different." As for job secutiry, Perrey says that "in some ways, knowing that your contract is up in six months is greater certainty than some of the permanent employees I have met have."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.